CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


22-May-2012
Certified Spiking Solutions® of the second generation anticonvulsant internal standards Lamotrigine-13C,15N4 & Gabapentin-D10 are now available.


Lamotrigine-13C, 15N4, L-022
500 ug/mL in Methanol

A certified solution and internal standard suitable for GC/MS or LC/MS applications such as clinical toxicology, urine drug testing, forensic analysis or isotope dilution methods. Lamotrigine is an antiepileptic drug marketed under the trade name Lamictal® for the treatment of epilepsy and bipolar disorder.

Gabapentin-D10, 1.0 mg/mL G-017
1.0 mg/mL in Methanol

Sold under the trade names Neurontin®, Nupentin®, or Gabarone®, gabapentin is an anticonvulsant drug used primarily for treatment of seizures, fibromyalgia, and chronic neuropathic pain. This internal standard is suitable for GC/MS or LC/MS testing or isotope dilution methods of gabapentin in forensic analysis, clinical toxicology, pain prescription monitoring, or urine drug testing.

Cerilliant will soon introduce Certified Spiking Solutions® of the anticonvulsants Lacosamide (Vimpat®) and Tiagabine (Gabitril®).



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn